HDAC4 Inhibitors
Santa Cruz Biotechnology now offers a broad range of HDAC4 Inhibitors. Histone deacetylase proteins (HDACs) are a class of enzymes that remove acetyl groups (O=C-CH3) from an <ε>-N-acetyl lysine amino acid on a histone, allowing histones to wrap DNA more tightly. The deacetylation of histones is associated with transcriptional silencing. Histone deacetylase inhibitors (HDIs) have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptic. HDIs are studied as a treatment for neurodegenerative diseases and have a potential for cancer therapy. HDAC4 Inhibitors offered by Santa Cruz inhibit HDAC4 and, in some cases, other chromatin remodeling and transcription regulation related proteins. View detailed HDAC4 Inhibitor specifications, including HDAC4 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tubastatin A | 1252003-15-8 | sc-507298 | 10 mg | $114.00 | ||
Tubastatin A HCl is a selective HDAC6 inhibitor that indirectly influences HDAC4. By modulating the activity of HDAC6, Tubastatin A HCl alters the acetylation status of substrates, potentially impacting HDAC4-regulated processes. This indirect modulation provides a unique perspective on the crosstalk between different HDACs and offers insights into how the inhibition of one HDAC can affect the function of another, such as HDAC4. | ||||||